Antibody glycosylation correlates with disease progression in SIV- Mycobacterium tuberculosis coinfected cynomolgus macaques.

Ebene R HaycroftTimon DamelangEster LopezMark A RodgersBruce D WinesMark HogarthCassaundra L AmeelStephen J KentCharles A ScangaShelby L O'ConnorAmy W Chung

Published in: Clinical & translational immunology (2023)

These studies suggest that humoral immunity may contribute to control of TB disease and support growing literature that highlights antibody Fc glycosylation as a biomarker of TB disease progression.

Keyphrases

mycobacterium tuberculosis
pulmonary tuberculosis
immune response
systematic review
case control